Standout Papers

Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcome... 2019 2026 2021 2023 532
  1. Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial (2019)
    Anders Widmark, Adalsteinn Gunnlaugsson et al. The Lancet

Immediate Impact

2 by Nobel laureates 38 from Science/Nature 64 standout
Sub-graph 1 of 23

Citing Papers

Radiotherapy toxicities: mechanisms, management, and future directions
2025 Standout
mTOR and neuroinflammation in epilepsy: implications for disease progression and treatment
2024 Standout
2 intermediate papers

Works of Per Nilsson being referenced

Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial
2019 Standout
Brain inflammation induces post-synaptic changes during early synapse formation in adult-born hippocampal neurons
2013
and 2 more

Author Peers

Author Last Decade Papers Cites
Per Nilsson 2142 1645 1165 227 6.7k
Pierre Richaud 1652 492 314 227 8.2k
Wei Xiong 1815 1207 965 126 4.1k
Kaiyuan Yu 2762 3731 2536 454 9.1k
Stefan Vogt 212 2211 742 293 11.4k
J. L. Matthews 703 238 250 258 6.4k
Robert Clough 1558 751 1031 126 4.4k
Barry Lai 284 2325 556 460 12.8k
J. David Robertson 621 293 1258 243 13.8k
Zhong Zhong 619 1250 793 269 10.5k
Steven Hancock 2624 1153 1727 187 10.0k

All Works

Loading papers...

Rankless by CCL
2026